The Long-Term Degradation Outcome of Bilok Screws Used for ACL Reconstruction

This study has been completed.
Sponsor:
Information provided by:
ArthroCare Corporation
ClinicalTrials.gov Identifier:
NCT00374491
First received: September 7, 2006
Last updated: September 21, 2007
Last verified: September 2007
  Purpose

The purpose of the study is to evaluate the long term outcome of a poly L-lactic acid / β-tricalcium phosphate (BILOK) biodegradable interference fixation screw used for arthroscopic bone-patellar tendon-bone ACL reconstruction,to determine if these BILOK screws completely biodegrade as expected three years after implantation, and to determine whether there is bone ingrowth into the defect remaining after resorption of the BILOK screw.


Condition Phase
Anterior Cruciate Ligament
Phase 4

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Cross-Sectional
Official Title: The Long-Term Degradation Outcome of Bilok Biodegradable Interference Fixation Screws Used for Bone-Patellar Tendon-Bone ACL Reconstruction

Resource links provided by NLM:


Further study details as provided by ArthroCare Corporation:

Estimated Enrollment: 20
Study Start Date: September 2006
Detailed Description:

BILOK screws have been used for ACL interference fixation in the US since the late 1990s. As yet, there are no long-term studies to demonstrate the eventual biologic outcome of these devices. Animal studies indicate that the material used in BILOK implants completely degrades after 3 years, but these reports do not indicate what takes their place. Reports of other screw materials indicate that pure PLLA screws remain intact and can be removed whole at revision surgery in the first few months to years after implantation. Recently a report of a biopsy at 2 years after surgery indicated that whole fragments of a PLLA screw were observed. Schwach and Vert suggested that a PDLLA screw (combination of dextro and levo stereoisomers) completely degrade and is replaced by bone 3 years after surgery in sheep but no information is available for the human. In addition to being limited and anecdotal, most studies evaluating the degradation of biodegradable screws used in humans are conducted using plain radiographs and MRI to evaluate the status of the biodegradable screws. A report by Bach et al evaluated the MRI appearance of a biodegradable interference screw composed of a different polymer (polyglycolic acid 67% and trimethylene carbonate 33%) in eight patients at 2 years. It showed the reabsorption of the screw but suggested that MRI is not the most effective method for determining the bone ingrowth status in the area of the resorbed screws. CT scanning is a better methodology than MRI for this application and was recently used to study the disappearance of a pure PLLA screw at least 7 years after implantation. The purpose of this study is to evaluate the long-term resorption status of a Bilok screw and determine, using CT scan, what material replaces the screw.

  Eligibility

Ages Eligible for Study:   18 Years to 55 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Prior patellar tendon autograft ACL reconstruction that used poly L-lactic acid (BILOK) interference fixation screws.
  • Minimum follow-up of 3 years after the index surgery.
  • Subject must be able to understand the verbiage of the consent form.
  • The subject must be willing to undergo a physical examination of the previously operated knee.
  • The subject must be willing to undergo a radiographic examination of the previously operated knee.
  • The subject must be willing to undergo a CT scan examination of the previously operated knee.
  • The subject signs the IRB-approved informed consent form.
  • The subject is willing and able to complete required follow-up.

Exclusion Criteria:

  • Subsequent ACL surgery or bone procedures in the area of the ACL graft attachments.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00374491

Locations
United States, Texas
Plano Orthopedic and Sports Medicine Center
Plano, Texas, United States, 75093
Sponsors and Collaborators
ArthroCare Corporation
Investigators
Principal Investigator: F. Alan Barber, MD
  More Information

Publications:

ClinicalTrials.gov Identifier: NCT00374491     History of Changes
Other Study ID Numbers: A0506JM, 20061028
Study First Received: September 7, 2006
Last Updated: September 21, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by ArthroCare Corporation:
ACL
Bone Screw
Knee

ClinicalTrials.gov processed this record on July 29, 2014